| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024008605 |
| P356 | DOI | 10.1007/S00401-009-0635-8 |
| P932 | PMC publication ID | 2849937 |
| P698 | PubMed publication ID | 20091409 |
| P5875 | ResearchGate publication ID | 41103724 |
| P50 | author | John T. O'Brien | Q37830687 |
| Masafumi Ihara | Q42656310 | ||
| Paul Ince | Q42856560 | ||
| Elisabet Englund | Q56589972 | ||
| P2093 | author name string | Raj N Kalaria | |
| Robert H Perry | |||
| Arthur E Oakley | |||
| Tuomo M Polvikoski | |||
| Ros Hall | |||
| Janet Y Slade | |||
| P2860 | cites work | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. | Q30813216 | ||
| Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. | Q30882166 | ||
| Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. | Q30908254 | ||
| Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium | Q34023599 | ||
| Axonal damage: a key predictor of outcome in human CNS diseases | Q34174912 | ||
| The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger’s Report | Q34299420 | ||
| Alterations in glia and axons in the brains of Binswanger's disease patients | Q34433021 | ||
| Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 | ||
| Similarities between Alzheimer's disease and vascular dementia | Q34989464 | ||
| Rett Syndrome -- an update | Q35136636 | ||
| White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging | Q35451667 | ||
| Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects | Q35467851 | ||
| Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens | Q35764331 | ||
| Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease | Q35774045 | ||
| White matter lesions impair frontal lobe function regardless of their location | Q35844738 | ||
| Towards defining the neuropathological substrates of vascular dementia. | Q35945432 | ||
| The enigma of vascular cognitive disorder and vascular dementia | Q36730292 | ||
| Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. | Q37299626 | ||
| Pathogenesis of leukoaraiosis: a review | Q41369515 | ||
| Cerebral vessels in ageing and Alzheimer's disease | Q41639782 | ||
| Medullary arteries in aging and dementia | Q44347066 | ||
| Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain | Q44616090 | ||
| Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging | Q44668515 | ||
| Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions | Q46160481 | ||
| Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease | Q46825969 | ||
| Topographical and cytopathological lesion analysis of the white matter in Binswanger's disease brains | Q47753395 | ||
| Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. | Q47824887 | ||
| Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. | Q48406159 | ||
| Frontal connections and cognitive changes in normal aging rhesus monkeys: a DTI study | Q48424981 | ||
| Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease | Q48497710 | ||
| Phases of A beta-deposition in the human brain and its relevance for the development of AD. | Q48567985 | ||
| White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury | Q48575517 | ||
| The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary | Q48662464 | ||
| Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. | Q48689416 | ||
| A Pi Form of Glutathione-S-Transferase Is a Myelin-and Oligodendrocyte-Associated Enzyme in Mouse Brain | Q48702530 | ||
| Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas | Q48743716 | ||
| Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study | Q48767861 | ||
| Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain | Q48825929 | ||
| Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. | Q48876836 | ||
| Age-related alterations in white matter microstructure measured by diffusion tensor imaging | Q48884470 | ||
| Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study | Q48937236 | ||
| Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia | Q49017095 | ||
| Differential degeneration of the cerebral microvasculature in Alzheimer's disease. | Q53202611 | ||
| Clinical Lewy body dementia and the impact of vascular components. | Q53232551 | ||
| Myelin breakdown in Alzheimer's disease: a commentary. | Q53259065 | ||
| Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. | Q53378017 | ||
| White Matter Hyperintensities Are Associated With Impairment of Memory, Attention, and Global Cognitive Performance in Older Stroke Patients | Q57813866 | ||
| Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis | Q73302186 | ||
| Neuropathological correlates to clinically defined dementia with Lewy bodies | Q74245351 | ||
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| vascular dementia | Q583908 | ||
| dementia with Lewy bodies | Q101245788 | ||
| P304 | page(s) | 579-589 | |
| P577 | publication date | 2010-01-21 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies | |
| P478 | volume | 119 |
| Q64124512 | A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology |
| Q59543627 | Adrenomedullin, a Novel Target for Neurodegenerative Diseases |
| Q45841436 | Age-dependent modification of proteins: N-terminal racemization |
| Q49294109 | An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers |
| Q37517131 | Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion |
| Q55415412 | Association between Alzheimer's disease pathogenesis and early demyelination and oligodendrocyte dysfunction. |
| Q46985283 | Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms |
| Q38020618 | Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system. |
| Q38232821 | Axonal transport defects in Alzheimer's disease |
| Q35767208 | Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts |
| Q47651485 | Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases |
| Q34275469 | Decreased oligodendrocyte nuclear diameter in Alzheimer's disease and Lewy body dementia |
| Q44839334 | Dementia: Vascular and neurodegenerative pathways-will they meet? |
| Q50547160 | Disrupted white matter structure underlies cognitive deficit in hypertensive patients. |
| Q59798063 | Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia |
| Q35852601 | Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion |
| Q47417382 | Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation |
| Q48656776 | Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus |
| Q36684570 | Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry |
| Q91955237 | Elevated Insulin and Insulin Resistance are Associated with Altered Myelin in Cognitively Unimpaired Middle-Aged Adults |
| Q92636791 | Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application |
| Q48361042 | Evaluation of Long-Term Cryostorage of Brain Tissue Sections for Quantitative Histochemistry. |
| Q34370861 | Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. |
| Q35868696 | Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia |
| Q36694586 | Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease |
| Q99711219 | HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia |
| Q38748464 | Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury |
| Q52330247 | Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage. |
| Q39114617 | Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes |
| Q35606711 | Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors |
| Q48773470 | Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease |
| Q89522904 | Microbleeds in dementia with Lewy bodies |
| Q92423945 | Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion |
| Q26824027 | Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain |
| Q48103598 | Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular disease |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q36595660 | Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias |
| Q48251767 | Myelin Detection Using Rapid Quantitative MR Imaging Correlated to Macroscopically Registered Luxol Fast Blue-Stained Brain Specimens |
| Q90011417 | Myelin Measurement: Comparison Between Simultaneous Tissue Relaxometry, Magnetization Transfer Saturation Index, and T1w/T2w Ratio Methods |
| Q35576628 | Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain |
| Q33791342 | Myelin injury and degraded myelin vesicles in Alzheimer's disease |
| Q41069446 | Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice |
| Q26750515 | Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease |
| Q60917211 | Neuropathology in intrauterine growth restricted newborn piglets is associated with glial activation and proinflammatory status in the brain |
| Q38497880 | Oligodendrocytes and Alzheimer's disease |
| Q36754568 | Pathology and pathogenesis of vascular cognitive impairment-a critical update |
| Q38730474 | Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases |
| Q48194042 | Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion |
| Q28394779 | Prenatal exposure of guinea pigs to the organophosphorus pesticide chlorpyrifos disrupts the structural and functional integrity of the brain |
| Q37387274 | Protective effects of carnosine on white matter damage induced by chronic cerebral hypoperfusion. |
| Q48689999 | Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias |
| Q47324557 | Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease. |
| Q38814687 | Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease? |
| Q35865696 | Staging and natural history of cerebrovascular pathology in dementia |
| Q36786383 | Stroke injury, cognitive impairment and vascular dementia |
| Q33964442 | Structural covariance of superficial white matter in mild Alzheimer's disease compared to normal aging. |
| Q36341689 | TREM2 regulates microglial cell activation in response to demyelination in vivo |
| Q46788633 | Tau proteins in the temporal and frontal cortices in patients with vascular dementia. |
| Q50593514 | The effects of environmental enrichment on white matter pathology in a mouse model of chronic cerebral hypoperfusion. |
| Q47136067 | The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease |
| Q38969718 | The impact of cerebrovascular aging on vascular cognitive impairment and dementia. |
| Q34402033 | The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia |
| Q34484708 | The overlap between vascular disease and Alzheimer's disease--lessons from pathology |
| Q36731049 | The role of cerebrovascular disease when there is concomitant Alzheimer disease |
| Q48691605 | Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology. |
| Q36127395 | Traumatic brain injury in young rats leads to progressive behavioral deficits coincident with altered tissue properties in adulthood |
| Q38238144 | Understanding and preventing the development of post-stroke dementia |
| Q47964631 | Update on Vascular Dementia |
| Q61797709 | White matter capillaries in vascular and neurodegenerative dementias |
| Q30880445 | White matter changes in dementia: role of impaired drainage of interstitial fluid. |
| Q47325037 | White matter degeneration in vascular and other ageing-related dementias |
| Q34515561 | White matter hyperintensities and imaging patterns of brain ageing in the general population |
| Q33864697 | White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. |
| Q33741447 | White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease |
| Q34805975 | White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). |
Search more.